@article{JGO18198,
author = {Shahid Ahmed and Mahjabeen Iqbal and Duc Le and Nayyer Iqbal and Punam Pahwa},
title = {Travel distance and use of salvage palliative chemotherapy in patients with metastatic colorectal cancer},
journal = {Journal of Gastrointestinal Oncology},
volume = {9},
number = {2},
year = {2018},
keywords = {},
abstract = {Background: Salvage palliative chemotherapy in metastatic colorectal cancer has been associated with signi cant improvement in survival. However, not all patients receive all available therapies. Travel burden can affect patient access and use of future therapy. The present study aims to determine relationship between travel distance (TD) and salvage palliative chemotherapy in patients with metastatic colorectal cancer.
Methods: A patient cohort diagnosed with metastatic colorectal cancer during 2006–2010 in the province of Saskatchewan, Canada was studied. Logistic regression analyses were performed to assess relationship between travel distance and subsequent line therapies.
Results: The median age of 264 eligible patients was 62 years [interquartile range (IQR): 53–72]. The patients who received salvage systemic therapy had a median distance to travel of 60.0 km (IQR: 4.7–144) compared with 88.1 km (IQR: 4.8–189) if they did not receive second- or third-line therapy (P=0.06). In multivariate analysis distance to the cancer center },
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/18198}
}